Experience with long-term use of certolizumab pegol (Cimzia)

Experience with long-term use of certolizumab pegol (Cimzia)

अन्य संस्करण दिखाएं (1)

<p>Objective: to establish whether long-term combination therapy with a tumor necrosis factor (TNF) α inhibitor and a disease-modifying antirheumatic drug (DMARD) (methotrexate – MTX) may lead to sustained rheumatoid arthritis (RA) remission and its maintenance even after discontinuation of ge...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Karine Arnoldovna Lytkina, G P Arutyunov
स्वरूप: लेख
भाषा:Russian
प्रकाशित: IMA-PRESS LLC 2013-10-01
श्रृंखला:Современная ревматология
विषय:
rheumatoid arthritis
genetically engineered biological agents
disease-modifying antirheumatic drugs
certolizumab pegol
ऑनलाइन पहुंच:http://mrj.ima-press.net/index.php/mrj/article/view/496

इंटरनेट

http://mrj.ima-press.net/index.php/mrj/article/view/496

समान संसाधन